Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,721 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $176.22 | 8 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $145.97 | 9 | $0 (2023) |
| ABBVIE INC. | $141.42 | 8 | $0 (2024) |
| Organogenesis Inc. | $117.04 | 6 | $0 (2022) |
| Novo Nordisk Inc | $116.28 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $106.46 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $101.40 | 6 | $0 (2024) |
| Medtronic, Inc. | $85.72 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $84.67 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $81.23 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $277.82 | 14 | Otsuka America Pharmaceutical, Inc. ($84.67) |
| 2023 | $125.39 | 7 | Amgen Inc. ($45.71) |
| 2022 | $314.96 | 11 | Organogenesis Inc. ($87.88) |
| 2021 | $169.01 | 10 | Lilly USA, LLC ($42.99) |
| 2020 | $135.59 | 9 | Novartis Pharmaceuticals Corporation ($33.09) |
| 2019 | $361.79 | 22 | Janssen Pharmaceuticals, Inc ($108.47) |
| 2018 | $236.70 | 13 | SANOFI-AVENTIS U.S. LLC ($81.23) |
| 2017 | $99.59 | 6 | GlaxoSmithKline, LLC. ($69.51) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.20 | General |
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Inflammation | ||||||
| 05/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Advanced Oxygen Therapy Inc. | Topical Oxygen Chamber for extremities (Device) | Food and Beverage | Cash or cash equivalent | $12.57 | General |
| Category: Topical Wound Oxygen | ||||||
| 04/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Inflammation | ||||||
| 11/03/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: VACCINES | ||||||
| 09/15/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Inflammation | ||||||
| 08/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Inflammation | ||||||
| 01/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/15/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: WOUND CARE | ||||||
| 11/11/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2022 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $85.72 | General |
| Category: Aortic Stent Grafts | ||||||
| 09/26/2022 | QorumPartners | Coala Heart Monitor (Device) | Food and Beverage | Cash or cash equivalent | $35.32 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,534 | 2,792 | $277,080 | $112,276 |
| 2022 | 25 | 1,297 | 4,549 | $519,227 | $181,417 |
| 2021 | 26 | 1,529 | 6,608 | $742,831 | $257,547 |
| 2020 | 37 | 2,118 | 5,118 | $486,938 | $170,646 |
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 428 | $68,052 | $33,605 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 419 | $48,185 | $19,719 | 40.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 129 | 129 | $45,150 | $15,267 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 92 | $20,424 | $9,588 | 46.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 37 | 37 | $12,950 | $9,102 | 70.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 23 | $6,900 | $4,267 | 61.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 55 | 106 | $15,900 | $3,767 | 23.7% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 15 | 86 | $6,364 | $2,512 | 39.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 126 | 255 | $10,200 | $2,374 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 168 | 282 | $4,230 | $2,319 | 54.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 52 | $2,080 | $1,422 | 68.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 49 | 49 | $1,960 | $1,394 | 71.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 132 | $5,280 | $1,123 | 21.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 50 | 50 | $8,750 | $1,051 | 12.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 28 | $2,240 | $1,028 | 45.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 38 | 57 | $1,710 | $861.84 | 50.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 24 | 66 | $3,300 | $815.10 | 24.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 130 | 184 | $1,840 | $620.62 | 33.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 24 | 42 | $3,360 | $616.36 | 18.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 15 | 88 | $4,400 | $369.60 | 8.4% |
| 85013 | Red blood cell hemoglobin concentration | Office | 2023 | 14 | 21 | $210.00 | $144.06 | 68.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 54 | 65 | $650.00 | $141.11 | 21.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,190 | $119.48 | 10.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 54 | 69 | $1,380 | $45.99 | 3.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 15 | $375.00 | $4.49 | 1.2% |
About Joseph Rupard, M D
Joseph Rupard, M D is a Family Medicine healthcare provider based in Shelbyville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861451338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Rupard, M D has received a total of $1,721 in payments from pharmaceutical and medical device companies, with $277.82 received in 2024. These payments were reported across 92 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,721).
As a Medicare-enrolled provider, Rupard has provided services to 6,478 Medicare beneficiaries, totaling 19,067 services with total Medicare billing of $721,885. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Shelbyville, TN
- Active Since 03/22/2006
- Last Updated 05/10/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861451338
Products in Payments
- XARELTO (Drug) $176.22
- Puraply (Medical Supply) $117.04
- ENTRESTO (Drug) $106.84
- ELIQUIS (Drug) $106.46
- ENDURANT IIS (Device) $85.72
- REXULTI (Drug) $84.67
- Otezla (Drug) $77.46
- SPECTRA WAVEWRITER (Device) $69.98
- ANORO (Drug) $69.51
- VRAYLAR (Drug) $68.46
- Tresiba (Drug) $67.30
- SUBLOCADE (Drug) $62.59
- TOUJEO (Drug) $43.97
- JARDIANCE (Drug) $42.99
- QULIPTA (Drug) $41.92
- LEQVIO (Drug) $39.13
- SOLIQUA (Drug) $37.26
- Coala Heart Monitor (Device) $35.32
- QUTENZA (Drug) $31.79
- UBRELVY (Drug) $31.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelbyville
Dr. Ron Creque, Md, MD
Family Medicine — Payments: $15,710
Paul Goodlett, Md, MD
Family Medicine — Payments: $14,867
Dr. David Oligschlaeger, D.o, D.O
Family Medicine — Payments: $11,457
Beth Buchanan, Md, MD
Family Medicine — Payments: $10,835
Dr. Emily Ann Andaya, Md, MD
Family Medicine — Payments: $8,149
Meredith Kehrer, Md, MD
Family Medicine — Payments: $6,265